最新发布
Deep innovation, limited capital define Argentina’s agrifoodtech opportunity
Bernardo Milesy is the founder and managing partner of GLOCAL, the Latin American agrifoodtech accelerator and investor,…
2022–2031 农化专利到期化合物:原研·中国·印度产业格局观察
一颗核心专利到期,让富美实手中曾经全球第一大的杀虫剂——氯虫苯甲酰胺,产业版图在几年间被悄然改写。这样的处境有一个清晰的名字:专利悬崖。
Lantmännen Harvest Forecast 2026: 5 Million Tonnes Of Grain
July 2026, Sweden: Following earlier descriptions of a challenging harvest situation, Lantmännen now quantifies the outl…
Prague: The up-and-coming biotech hub in Central Europe
Long renowned for its rich history, striking architecture, and thriving technology sector, Prague – and Czechia as a whole – is increasingly gaining recognition for something else: a fast-growing life sciences ecosystem. Prague’s biotech hub currently has a lot going for it, including world-class scientific research, an expanding network of innovative startups and specialized biotechs, the presence of big pharma companies, and growing investor interest. Put all this together, and it means the Czech capital is now emerging as one of Central Europe’s most promising biotech hubs.
AlzeCure licenses Alzheimer’s asset to QuantumCell in $2.2bn deal
Why it matters: The agreement gives AlzeCure another non-dilutive financing route for its CNS pipeline, shortly after the company signed a separate outlicensing deal with Eli Lilly for its Alzstatin platform.
Spring Innovation Fund debuts as first venture philanthropy firm dedicated to animal welfare tech
Are animal welfare and economics fundamentally at odds? Not necessarily, say the founders of Spring Innovation Fund, a n…
Ipsen’s buying streak continues with €700m Memo deal
Why it matters: It is Ipsen’s second acquisition in a week, following its up-to-$1.75bn deal for Kartos Therapeutics. In two moves, the French pharma has added one late-stage oncology asset and one mid-stage rare-disease programme, reinforcing its strategy of buying niche medicines with clear development paths.
Remembering World Food Prize Laureate Mary-Dell Chilton
July 2026, US: On behalf of the World Food Prize Laureates and our Council of Advisors, the World Food Prize Foundation …
In Huntington’s Mouse, Optogenetic Activation of VIP Neurons Restores Brain Function
Huntington’s disease is a devastating brain disorder in which damage to nerve cells leads to progressively worsening cognitive and movement abilities. While the genetic mutation responsible for the condition is well known, the details of how the disease disrupts brain circuits have not been clearly understood. Now, researchers have identified and tracked neurons involved in Huntington’s disease progression and used optogenetics to selectively activate these neurons and improve the debilitating deficits of the condition.
Exclusive: Bayou Best Foods acquires BettaF!sh to build global presence in plant-based seafood
US-based Bayou Best Foods has acquired German startup BettaF!sh (Wunderfish) to create a global plant-based seafood oper…
